CD8A and neoplasm: Notably, early-stage vaccination induces a striking anti-cancer effect, underscoring the critical role of MHC-II neoantigens alongside MHC-I antigen prediction in shaping effective anti-tumor immunity, in the activation of antigen-specific CD8<sup>+</sup> T cells.